16.09.2011 • News

DuPont CEO Ellen Kullman Releases Statement On America Invents Act

DuPont's Chair and CEO Ellen Kullman said in a statement that the America Invents Act will help the company more quickly convert its almost $2 billion per year investment in research and development into innovations the company can bring to market with strong patent protection.

Ellen Kullman attended the signing of The America Invents Act (HR 1249) by U.S. President Barack Obama today. Kullman is a member of the President's Council on Jobs and Competitiveness.

Ellen Kullman said, "The Act will speed R&D investment, new product development and the creation of jobs. It also will align the U.S. patent system more effectively with those of our global trading partners."

DuPont

Interview

Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.